ABCG2 and cancer: The MDR to chemotherapeutic drugs in cancer cells is mediated through a mechanism involving P-glycoprotein (P-gp, or MDR1), multidrug resistance-associated protein 1 (MRP1, or ABCC1), or breast cancer resistance protein (BCRP, or ABCG2) [9,80].